Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) SHZ
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Shanghai Kaibao Pharmaceutical CO.,Ltd
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1325
First IPO Date
January 08, 2010
Key Executives
| Name | Title | Pay | Year Born |
| Yingbin Zhou | GM & Director | 0 | 1978 |
| Liwang Ren | Board Secretary & Non-Independent Director | 0 | 1970 |
| Jianzhong Liu | Deputy GM & Non-Independent Director | 0 | 1973 |
| Ya Ru Li | Accounting Supervisor | 0 | N/A |
| Ying Jun Zhu | Deputy General Manager | 0 | 1970 |
| You Long Chen | Financial Director | 0 | 1975 |
Description
Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research, development, manufacturing, and sale of modern Traditional Chinese Medicines, primarily operating within China. Its diverse product lineup features several key pharmaceutical solutions. These include: Tanreqing injection, which is extensively utilized for addressing conditions like pneumonia, acute and chronic bronchitis, and upper respiratory tract infections. Tanreqing capsules, formulated to reduce internal heat, detoxify the system, and clear phlegm. Tiopronin for injection, designed to enhance liver function for various acute and chronic hepatitis patients. Tiopronin enteric-coated tablets, prescribed as a supplementary therapy for managing chronic hepatitis. Xiongdan dropping pills, known for their efficacy in alleviating heat, calming the liver, and promoting improved vision. Established in 2000, the company's operations are based in Shanghai, China.